Showing 1 - 6 of 6
The U.S. 2009 Tobacco Control Act opened the door for new anti-smoking policies by giving the Food and Drug Administration broad regulatory authority over the tobacco industry. We develop a behavioral welfare economics approach to conduct cost-benefit analysis of FDA tobacco regulations. We use...
Persistent link: https://www.econbiz.de/10012981623
Persistent link: https://www.econbiz.de/10011563020
The U.S. 2009 Tobacco Control Act opened the door for new anti-smoking policies by giving the Food and Drug Administration broad regulatory authority over the tobacco industry. We develop a behavioral welfare economics approach to conduct cost-benefit analysis of FDA tobacco regulations. We use...
Persistent link: https://www.econbiz.de/10012455962
Tobacco regulation has been a major component of health policy in the developed world since the UK's Royal College of Physicians' and the U.S. Surgeon General's reports in the 1960s. Such regulation, which has intensified in the past two decades, includes cigarette taxation, place-based smoking...
Persistent link: https://www.econbiz.de/10012837807
Tobacco regulation has been a major component of health policy in the developed world since the UK's Royal College of Physicians' and the U.S. Surgeon General's reports in the 1960s. Such regulation, which has intensified in the past two decades, includes cigarette taxation, place-based smoking...
Persistent link: https://www.econbiz.de/10012481881
The U.S. 2009 Tobacco Control Act opened the door for new antismoking policies by giving the Food and Drug Administration broad regulatory authority over the tobacco industry. We develop a behavioral welfare economics approach to conduct cost-benefit analysis of FDA tobacco regulations. We use a...
Persistent link: https://www.econbiz.de/10015363302